C163H165F4N21O16S2 — CID 161086765
1-[2-(1H-benzimidazol-2-yl)acetyl]-5,5-difluoro-N-(4-methylphenyl)piperidine-3-carboxamide;1-[2-(1-benzofuran-2-yl)acetyl]-N-(4-methylphenyl)piperidine-3-carboxamide;5,5-difluoro-N-(4-methylphenyl)-1-(3-pyridin-4-ylbenzoyl)piperidine-3-carboxamide;1-(3H-indole-2-carbonyl)-N-(4-methylphenyl)piperidine-3-carboxamide;N-(4-methylphenyl)-1-(5-methyl-2-phenyl-1,3-oxazole-4-carbonyl)piperidine-3-carboxamide;N-(4-methylphenyl)-1-(4-methyl-2-phenyl-1,3-thiazole-5-carbonyl)piperidine-3-carboxamide;N-(4-methylphenyl)-1-(2-phenyl-1,3-thiazole-4-carbonyl)piperidine-3-carboxamide (PubChem CID 161086765) has the molecular formula C163H165F4N21O16S2 and a molecular weight of 2814.37 g/mol. Its IUPAC name is 1-[2-(1H-benzimidazol-2-yl)acetyl]-5,5-difluoro-N-(4-methylphenyl)piperidine-3-carboxamide;1-[2-(1-benzofuran-2-yl)acetyl]-N-(4-methylphenyl)piperidine-3-carboxamide;5,5-difluoro-N-(4-methylphenyl)-1-(3-pyridin-4-ylbenzoyl)piperidine-3-carboxamide;1-(3H-indole-2-carbonyl)-N-(4-methylphenyl)piperidine-3-carboxamide;N-(4-methylphenyl)-1-(5-methyl-2-phenyl-1,3-oxazole-4-carbonyl)piperidine-3-carboxamide;N-(4-methylphenyl)-1-(4-methyl-2-phenyl-1,3-thiazole-5-carbonyl)piperidine-3-carboxamide;N-(4-methylphenyl)-1-(2-phenyl-1,3-thiazole-4-carbonyl)piperidine-3-carboxamide.
| Compound Name | 1-[2-(1H-benzimidazol-2-yl)acetyl]-5,5-difluoro-N-(4-methylphenyl)piperidine-3-carboxamide;1-[2-(1-benzofuran-2-yl)acetyl]-N-(4-methylphenyl)piperidine-3-carboxamide;5,5-difluoro-N-(4-methylphenyl)-1-(3-pyridin-4-ylbenzoyl)piperidine-3-carboxamide;1-(3H-indole-2-carbonyl)-N-(4-methylphenyl)piperidine-3-carboxamide;N-(4-methylphenyl)-1-(5-methyl-2-phenyl-1,3-oxazole-4-carbonyl)piperidine-3-carboxamide;N-(4-methylphenyl)-1-(4-methyl-2-phenyl-1,3-thiazole-5-carbonyl)piperidine-3-carboxamide;N-(4-methylphenyl)-1-(2-phenyl-1,3-thiazole-4-carbonyl)piperidine-3-carboxamide |
|---|---|
| PubChem CID | 161086765 |
| Molecular Formula | C163H165F4N21O16S2 |
| Molecular Weight | 2814.37 g/mol |
| Exact Mass | 2812.21 |
| IUPAC Name | 1-[2-(1H-benzimidazol-2-yl)acetyl]-5,5-difluoro-N-(4-methylphenyl)piperidine-3-carboxamide;1-[2-(1-benzofuran-2-yl)acetyl]-N-(4-methylphenyl)piperidine-3-carboxamide;5,5-difluoro-N-(4-methylphenyl)-1-(3-pyridin-4-ylbenzoyl)piperidine-3-carboxamide;1-(3H-indole-2-carbonyl)-N-(4-methylphenyl)piperidine-3-carboxamide;N-(4-methylphenyl)-1-(5-methyl-2-phenyl-1,3-oxazole-4-carbonyl)piperidine-3-carboxamide;N-(4-methylphenyl)-1-(4-methyl-2-phenyl-1,3-thiazole-5-carbonyl)piperidine-3-carboxamide;N-(4-methylphenyl)-1-(2-phenyl-1,3-thiazole-4-carbonyl)piperidine-3-carboxamide |
| SMILES | Cc1ccc(NC(=O)C2CCCN(C(=O)C3=Nc4ccccc4C3)C2)cc1.Cc1ccc(NC(=O)C2CCCN(C(=O)Cc3cc4ccccc4o3)C2)cc1.Cc1ccc(NC(=O)C2CCCN(C(=O)c3csc(-c4ccccc4)n3)C2)cc1.Cc1ccc(NC(=O)C2CCCN(C(=O)c3nc(-c4ccccc4)oc3C)C2)cc1.Cc1ccc(NC(=O)C2CCCN(C(=O)c3sc(-c4ccccc4)nc3C)C2)cc1.Cc1ccc(NC(=O)C2CN(C(=O)Cc3nc4ccccc4[nH]3)CC(F)(F)C2)cc1.Cc1ccc(NC(=O)C2CN(C(=O)c3cccc(-c4ccncc4)c3)CC(F)(F)C2)cc1 |
| InChI | InChI=1S/C25H23F2N3O2.C24H25N3O3.C24H25N3O2S.C23H23N3O2S.C23H24N2O3.C22H22F2N4O2.C22H23N3O2/c1-17-5-7-22(8-6-17)29-23(31)21-14-25(26,27)16-30(15-21)24(32)20-4-2-3-19(13-20)18-9-11-28-12-10-18;1-16-10-12-20(13-11-16)25-22(28)19-9-6-14-27(15-19)24(29)21-17(2)30-23(26-21)18-7-4-3-5-8-18;1-16-10-12-20(13-11-16)26-22(28)19-9-6-14-27(15-19)24(29)21-17(2)25-23(30-21)18-7-4-3-5-8-18;1-16-9-11-19(12-10-16)24-21(27)18-8-5-13-26(14-18)23(28)20-15-29-22(25-20)17-6-3-2-4-7-17;1-16-8-10-19(11-9-16)24-23(27)18-6-4-12-25(15-18)22(26)14-20-13-17-5-2-3-7-21(17)28-20;1-14-6-8-16(9-7-14)25-21(30)15-11-22(23,24)13-28(12-15)20(29)10-19-26-17-4-2-3-5-18(17)27-19;1-15-8-10-18(11-9-15)23-21(26)17-6-4-12-25(14-17)22(27)20-13-16-5-2-3-7-19(16)24-20/h2-13,21H,14-16H2,1H3,(H,29,31);3-5,7-8,10-13,19H,6,9,14-15H2,1-2H3,(H,25,28);3-5,7-8,10-13,19H,6,9,14-15H2,1-2H3,(H,26,28);2-4,6-7,9-12,15,18H,5,8,13-14H2,1H3,(H,24,27);2-3,5,7-11,13,18H,4,6,12,14-15H2,1H3,(H,24,27);2-9,15H,10-13H2,1H3,(H,25,30)(H,26,27);2-3,5,7-11,17H,4,6,12-14H2,1H3,(H,23,26) |
| InChIKey | UGPUMJSKDDLMHX-UHFFFAOYSA-N |
| XLogP | 29.97 |
| TPSA | 464.75 Ų |
| H-Bond Donors | 8 |
| H-Bond Acceptors | 24 |
| Rotatable Bonds | 27 |
| Heavy Atoms | 206 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2814.37 |
| LogP ≤ 5 | 29.97 |
| H-Bond Donors ≤ 5 | 8 |
| H-Bond Acceptors ≤ 10 | 24 |